000 01411 a2200397 4500
005 20250514183033.0
264 0 _c20040601
008 200406s 0 0 fre d
022 _a0151-9638
024 7 _a10.1016/s0151-9638(04)93537-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoƫlle, P-Y
245 0 0 _a[An epidemiological model of genital herpes for assessment of potential impact of therapy and prophylaxis: application to France].
_h[electronic resource]
260 _bAnnales de dermatologie et de venereologie
_cJan 2004
300 _a17-26 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aFrance
_xepidemiology
650 0 4 _aHerpes Genitalis
_xepidemiology
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aModels, Statistical
650 0 4 _aRecurrence
650 0 4 _aSeroepidemiologic Studies
650 0 4 _aVirus Shedding
700 1 _aFagnani, F
700 1 _aValleron, A-J
700 1 _aDetournay, B
700 1 _aEl Hasnaoui, A
700 1 _aHalioua, B
700 1 _aNicolas, J-C
773 0 _tAnnales de dermatologie et de venereologie
_gvol. 131
_gno. 1 Pt 1
_gp. 17-26
856 4 0 _uhttps://doi.org/10.1016/s0151-9638(04)93537-5
_zAvailable from publisher's website
999 _c14758992
_d14758992